Cargando…

Use and positioning of fostamatinib in the management of primary chronic immune thrombocytopenia: an Italian expert opinion

Fostamatinib, a spleen tyrosine kinase (Syk) inhibitor, represents a new therapeutic opportunity for patients with immune thrombocytopenia (ITP) in Europe and Italy. However, the positioning of this drug in patient’s therapeutic sequence is undefined within the most recent international guidelines....

Descripción completa

Detalles Bibliográficos
Autores principales:	Lucchesi, Alessandro, Fattizzo, Bruno, De Stefano, Valerio, Ruggeri, Marco, Siragusa, Sergio, Vianelli, Nicola, Zaja, Francesco, Rodeghiero, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326469/ https://www.ncbi.nlm.nih.gov/pubmed/37426835 http://dx.doi.org/10.1177/20406207221147777

Ejemplares similares

Practical Recommendations for the Management of Patients with ITP During the COVID-19 Pandemic
por: Rodeghiero, Francesco, et al.
Publicado: (2021)

Second-line administration of thrombopoietin receptor agonists in immune thrombocytopenia: Italian Delphi-based consensus recommendations
por: Carpenedo, Monica, et al.
Publicado: (2021)

Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo‐controlled trials
por: Bussel, James, et al.
Publicado: (2018)

Fostamatinib is an effective second‐line therapy in patients with immune thrombocytopenia
por: Boccia, Ralph, et al.
Publicado: (2020)

Fostamatinib in chronic immune thrombocytopenia: a profile of its use in the USA
por: McKeage, Kate, et al.
Publicado: (2018)

Two Refractory Immune Thrombocytopenia Case Reports Showing Responsiveness to Fostamatinib
por: Innao, Vanessa, et al.
Publicado: (2023)

Correction to: Fostamatinib in chronic immune thrombocytopenia: a profile of its use in the USA
por: McKeage, Kate, et al.
Publicado: (2018)

Assessment of thrombotic risk during long-term treatment of immune thrombocytopenia with fostamatinib
por: Cooper, Nichola, et al.
Publicado: (2021)

Sustained response off therapy after fostamatinib: A chronic refractory ITP case report
por: Auteri, Giuseppe, et al.
Publicado: (2023)

Pillars for prevention and control of healthcare-associated infections: an Italian expert opinion statement
por: Puro, Vincenzo, et al.
Publicado: (2022)

Immune Thrombocytopenia in Antiphospholipid Syndrome: Is It Primary or Secondary?
por: Tomasello, Riccardo, et al.
Publicado: (2021)

Immune thrombocytopenia in myeloid and lymphoid clonal disorders: an intriguing association
por: Rodeghiero, Francesco
Publicado: (2021)

Long‐term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program
por: Bussel, James B., et al.
Publicado: (2019)

How to Treat COVID-19 Patients at Home in the Italian Context: An Expert Opinion
por: Donno, Davide Roberto, et al.
Publicado: (2021)

The Efficacy and Safety of Fostamatinib in Elderly Patients with Immune Thrombocytopenia: A Single-Center, Real-World Case Series
por: Liu, Jessica, et al.
Publicado: (2022)

Long-Term Spasticity Management in Post-Stroke Patients: Issues and Possible Actions—A Systematic Review with an Italian Expert Opinion
por: Morone, Giovanni, et al.
Publicado: (2023)

Nationwide Survey on the Use of Thrombopoietin Receptor Agonists (TPO-RA) for the Management of Immune Thrombocytopenia in Current Clinical Practice in Italy
por: Napolitano, Mariasanta, et al.
Publicado: (2023)

561. Phase 3 Trial of Fostamatinib for the Treatment of COVID-19: Repurposing an Immunomodulatory Drug Previously Approved for Immune Thrombocytopenia
por: Mallat, Ziad, et al.
Publicado: (2021)

X-linked hypophosphatemic rickets: an Italian experts’ opinion survey
por: Emma, F., et al.
Publicado: (2019)

Antithrombotic Effects of Fostamatinib in Combination with Conventional Antiplatelet Drugs
por: Harbi, Maan H., et al.
Publicado: (2022)

Management of Opioid-Induced Constipation and Bowel Dysfunction: Expert Opinion of an Italian Multidisciplinary Panel
por: De Giorgio, Roberto, et al.
Publicado: (2021)

Rituximab in the treatment of immune thrombocytopenia: what is the role of this agent in 2019?
por: Lucchini, Elisa, et al.
Publicado: (2019)

Experts Opinion
por: Goldberg, Ivan, et al.
Publicado: (2012)

Expert Opinion
Publicado: (1920)

Prevention of fostamatinib-induced blood pressure elevation by antihypertensive agents
por: Lengel, Dave, et al.
Publicado: (2015)

S298: MATERNAL AND FETAL OUTCOMES IN PREGNANCIES OF WOMEN WITH IMMUNE THROMBOCYTOPENIA: A MULTICENTER RETROSPECTIVE OBSERVATIONAL ITP-NET ITALIAN STUDY
por: Carpenedo, Monica, et al.
Publicado: (2023)

Diagnosis and management of symptoms associated with vulvovaginal atrophy: expert opinion on behalf of the Italian VVA study group (*)
por: Nappi, Rossella E., et al.
Publicado: (2016)

Clinical Pharmacokinetics and Pharmacodynamics of Fostamatinib and Its Active Moiety R406
por: Matsukane, Ryosuke, et al.
Publicado: (2022)

Expert Opinion on the Management of Growth Hormone Deficiency in Brain Tumor Survivors: Results From an Italian Survey
por: Di Iorgi, Natascia, et al.
Publicado: (2022)

More Expert Opinion
Publicado: (1920)

Expert opinion of an Italian working group on the assessment of cognitive, psychological, and neurological outcomes in pediatric, adolescent, and adult patients with phenylketonuria
por: Manti, Filippo, et al.
Publicado: (2022)

P1614: TAPERING SCHEME AND SUSTAINED RESPONSE IN PATIENTS WITH ITP TREATED WITH FOSTAMATINIB
por: Mingot-Castellano, María Eva, et al.
Publicado: (2023)

Changes in bone marrow morphology in adults receiving romiplostim for the treatment of thrombocytopenia associated with primary immune thrombocytopenia
por: Janssens, Ann, et al.
Publicado: (2016)

Romiplostim as early treatment of immune thrombocytopenia with severe immunodeficiency
por: Palandri, Francesca, et al.
Publicado: (2012)

Patellofemoral arthroplasty: expert opinion
por: Hoogervorst, Paul, et al.
Publicado: (2022)

Correction: Expert opinion of an Italian working group on the assessment of cognitive, psychological, and neurological outcomes in pediatric, adolescent, and adult patients with phenylketonuria
por: Manti, Filippo, et al.
Publicado: (2023)

Role of Mesotherapy in Musculoskeletal Pain: Opinions from the Italian Society of Mesotherapy
por: Mammucari, Massimo, et al.
Publicado: (2012)

Repurposing Fostamatinib to Combat SARS-CoV-2-Induced Acute Lung Injury
por: Tabassum, Neha, et al.
Publicado: (2020)

The Cardiovascular Risks of Fostamatinib in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
por: Chen, Yuehong, et al.
Publicado: (2021)

Prior and Posterior Linear Pooling for Combining Expert Opinions: Uses and Impact on Bayesian Networks—The Case of the Wayfinding Model
por: Farr, Charisse, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_351pk7s2ardi0ivkkv2uuhvcjo